Biologia, Bratislava, 56/Suppl. 9: 119-122, 2001.

ISSN 0006-3088 (Biologia). ISSN 1335-6399 (Biologia. Section Cellular and Molecular Biology).

 

Full Paper

Cost effectiveness and cost benefit analysis of the regular obligatory vaccination in Slovakia.

 

Henrieta Hudeckova*, Stefan Straka & Maria Szilagyiova

State Institute of Health Martin, Kuzmanyho 27, SK-03680 Martin, Slovakia; tel.: ++ 421 842 4230791, fax: ++421 842 4134863, e.mail: hudeckova@mail.viapvt.sk

* corresponding author

Received: December 28, 2000 / Accepted: April 23, 2001

 

Abstract

Vaccination is a cost effective preventive measure, which has become a priority in our primary prevention. The aim of this contribution was an economic evaluation of the regular obligatory vaccination of children in Slovak Republic funded from state budget. For our evaluation we used the prepared model (the period before vaccination was introduced), official reports on epidemiological situation, economic and statistical data, costs of treatment of the affected, costs of vaccination, as well as absenteeism, losses of productivity and losses of the gross domestic product in 1996. In cost effectiveness analysis (CEA) we compared the cost before a after introduction of vaccination and evaluated its efficacy (99%). Cost effectiveness represented in average 12 thousand Slovak crowns (Sk) per one case of disease prevented by vaccination. Cost benefit analysis (CBA) has shown significant saving in the form of medical costs for treatment. The calculated benefit accounting for 8.30 Sk represented the saved costs per one Sk invested in vaccination.

 

Key words: regular obligatory vaccination, cost effectiveness, cost benefit.